By immunohistochemistry, a difference in glutaminase expression levels between the different tumour grades was identified (ANOVA, p = 0.001), and the post-hoc analysis revealed that specifically the grade II tumours and the grade III tumours had higher expression levels compared to the ACTs (both p = 0.001) (Fig. 2a-e). Here, GLS is linked to neoplasm.